SIGA Price Prediction, SIGA Technologies AI Recommendations

Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
published Dividends

SIGA paid dividends on April 11, 2024

SIGA Technologies SIGA Stock Dividends
А quarterly dividend of $0.60 per share was paid with a record date of April 11, 2024, and an ex-dividend date of March 25, 2024. Read more...
published Highlights

Notable companies

The most notable companies in this group are ZOETIS (NYSE:ZTS), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Elanco Animal Health (NYSE:ELAN), Intra-Cellular Therapies (NASDAQ:ITCI), Bausch Health Companies (NYSE:BHC), Tilray Brands (NASDAQ:TLRY), Avadel Pharmaceuticals plc (NASDAQ:AVDL), Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 3.16B. The market cap for tickers in the group ranges from 246 to 77.48B. ZTS holds the highest valuation in this group at 77.48B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was 2%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 49%. RGC experienced the highest price growth at 321%, while MGWFF experienced the biggest fall at -48%.


The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was 33%. For the same stocks of the Industry, the average monthly volume growth was 65% and the average quarterly volume growth was 72%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 71
Price Growth Rating: 51
SMR Rating: 87
Profit Risk Rating: 92
Seasonality Score: 0 (-100 ... +100)
View a ticker or compare two or three
Ad is loading...
published price charts
A.I. Advisor
published General Information

General Information

a developer of vaccines and antibiotics for the prevention and treatment of serious infectious diseases

Industry PharmaceuticalsOther

Pharmaceuticals Other
31 East 62nd Street
+1 212 672-9100